Mice chronically fed high-fat diet have increased mortality and disturbed immune response in sepsis

PLoS ONE

Volumn 4, Issue 10, 2009, Pages

  Stranberg, Louise ^a   Verdrengh, Margareta ^b   Enge, Maria ^a   Andersson, Niklas ^a   Amu, Sylvie ^b,d   Önnheim, Karin ^b   Benrick, Anna ^a,e   Brisslert, Mikael ^b   Bylund, Johan ^b   Bokarewa, Maria ^b   Nilsson, Staffan ^c   Jansson, John Olov ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^d ST JAMES S HOSPITAL   (Ireland)

^e GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; MESSENGER RNA; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CELL COUNT; CONTROLLED STUDY; FOOD COMPOSITION; IMMUNE RESPONSE; IMMUNOPATHOLOGY; LIPID BLOOD LEVEL; LIPID DIET; LOW FAT DIET; MACROPHAGE FUNCTION; MALE; MORTALITY; MOUSE; MOUSE MUTANT; NONHUMAN; PERITONEUM CELL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; STAPHYLOCOCCAL BACTEREMIA; ANIMAL; ANIMAL FOOD; BIOLOGICAL MODEL; C57BL MOUSE; FAT INTAKE; GENETICS; IMMUNOLOGY; KIDNEY; METABOLISM; OBESITY; SEPSIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TIME;

BACTERIA (MICROORGANISMS); MUS; POSIBACTERIA; STAPHYLOCOCCUS AUREUS;

ANIMAL FEED; ANIMALS; DIET, FAT-RESTRICTED; DIETARY FATS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-10; KIDNEY; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; MODELS, GENETIC; OBESITY; SEPSIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TIME FACTORS;

EID: 70449578205     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007605     Document Type: Article

References (55)

1. Martin GS, Mannino DM, Eaton S, Moss M (2003) The Epidemiology of Sepsis in the United States from 1979 through 2000. N Engl J Med 348: 1546-1554.
2. Benfield T, Espersen F, Frimodt-Møller N, Jensen AG, Larsen AR, et al. (2007) Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000. Clin Microbiol Infect 13: 257-263.
3. Hotchkiss RS, Karl IE (2003) The Pathophysiology and Treatment of Sepsis. N Engl J Med 348: 138-150.
4. Deitch EA (1998) Animal models of sepsis and shock: a review and lessons learned. Shock 9: 1-11.
5. Russell JA (2006) Management of sepsis. N Engl J Med 355: 1699-1713.
6. Levy SB, Marshall B (2004) Antibacterial resistance worldwide: causes, challenges and responses. Nat Med 10: S122-129.
7. (2003) Diet, nutrition and the prevention of chronic diseases. World Health Organ Tech Rep Ser 916: i-viii, 1-149, backcover.
8. James WPT (2008) The fundamental drivers of the obesity epidemic. Obesity Reviews 9: 6-13.
9. Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259: 87-91.
10. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112: 1796-1808.
11. Xu H, Barnes GT, Yang Q, Tan G, Yang D, et al. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112: 1821-1830.
12. Wellen KE, Hotamisligil GS (2005) Inflammation, stress, and diabetes. J Clin Invest 115: 1111-1119.
13. Falagas ME, Kompoti M (2006) Obesity and infection. Lancet Infect Dis 6: 438-446.
14. Wallenius V, Wallenius K, Ahren B, Rudling M, Carlsten H, et al. (2002) Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 8: 75-79.
15. Reed JA, Clegg DJ, Blake Smith K, Tolod-Richer EG, Matter EK, et al. (2005) GM-CSF action in the CNS decreases food intake and body weight. J Clin Invest 115: 3035-3044.
16. Garcia MC, Wernstedt I, Berndtsson A, Enge M, Bell M, et al. (2006) Mature-onset obesity in interleukin-1 receptor I knockout mice. Diabetes 55: 1205-1213.
17. Chida D, Osaka T, Hashimoto O, Iwakura Y (2006) Combined interleukin-6 and interleukin-1 deficiency causes obesity in young mice. Diabetes 55: 971-977.
18. Netea MG, Joosten LAB, Lewis E, Jensen DR, Voshol PJ, et al. (2006) Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance. Nat Med 12: 650-656.
19. Zorrilla EP, Sanchez-Alavez M, Sugama S, Brennan M, Fernandez R, et al. (2007) Interleukin-18 controls energy homeostasis by suppressing appetite and feed efficiency. Proc Natl Acad Sci U S A 104: 11097-11102.
20. Robinson SW, Dinulescu DM, Cone RD (2000) Genetic models of obesity and energy balance in the mouse. Annu Rev Genet 34: 687-745.
21. Collins S, Martin TL, Surwit RS, Robidoux J (2004) Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics. Physiol Behav 81: 243-248.
22. Verdrengh M, Tarkowski A (1997) Role of neutrophils in experimental septicemia and septic arthritis induced by Staphylococcus aureus. Infect Immun 65: 2517-2521.
23. Strandberg L, Lorentzon M, Hellqvist A, Nilsson S, Wallenius V, et al. (2006) Interleukin-1 system gene polymorphisms are associated with fat mass in young men. J Clin Endocrinol Metab 91: 2749-2754.
24. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
25. Perfetto SP, Chattopadhyay PK, Roederer M (2004) Seventeen-colour flow cytometry: unravelling the immune system. Nat Rev Immunol 4: 648-655.
26. Dahlgren C, Karlsson A, Bylund J (2007) Measurement of respiratory burst products generated by professional phagocytes. Methods Mol Biol 412: 349-363.
27. Itou T, Collins LV, Thoren FB, Dahlgren C, Karlsson A (2006) Changes in Activation States of Murine Polymorphonuclear Leukocytes (PMN) during Inflammation: a Comparison of Bone Marrow and Peritoneal Exudate PMN. Clin Vaccine Immunol 13: 575-583.
28. Boxio R, Bossenmeyer-Pourie C, Steinckwich N, Dournon C, Nusse O (2004) Mouse bone marrow contains large numbers of functionally competent neutrophils. J Leukoc Biol 75: 604-611.
29. Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, et al. (1998) IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 101: 311-320.
30. Starkie R, Ostrowski SR, Jauffred S, Febbraio M, Pedersen BK (2003) Exercise and IL-6 infusion inhibit endotoxin-induced TNF-α production in humans. FASEB J: 02-0670fje.
31. Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, et al. (2005) IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 11: 191-198.
32. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, et al. (2005) Local and systemic insulin resistance resulting from hepatic activation of IKK-[beta] and NF-[kappa]B. Nat Med 11: 183-190.
33. Fessler BJ (2002) Infectious diseases in systemic lupus erythematosus: risk factors, management and prophylaxis. Best Pract Res Clin Rheumatol 16: 281-291.
34. Mikuls TR (2003) Co-morbidity in rheumatoid arthritis. Best Pract Res Clin Rheumatol 17: 729-752.
35. Juge-Aubry CE, Somm E, Chicheportiche R, Burger D, Pernin A, et al. (2004) Regulatory effects of interleukin (IL)-1, interferon-beta, and IL-4 on the production of IL-1 receptor antagonist by human adipose tissue. J Clin Endocrinol Metab 89: 2652-2658.
36. Juge-Aubry CE, Somm E, Pernin A, Alizadeh N, Giusti V, et al. (2005) Adipose tissue is a regulated source of interleukin-10. Cytokine 29: 270-274.
37. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, et al. (1997) Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-{alpha}, in Vivo. J Clin Endocrinol Metab 82: 4196-4200.
38. Ashare A, Powers LS, Butler NS, Doerschug KC, Monick MM, et al. (2005) Anti-inflammatory response is associated with mortality and severity of infection in sepsis. Am J Physiol Lung Cell Mol Physiol 288: L633-640.
39. Song GY, Chung CS, Chaudry IH, Ayala A (1999) What is the role of interleukin 10 in polymicrobial sepsis: anti-inflammatory agent or immunosuppressant? Surgery 126: 378-383.
40. Winkelstein JA, Marino MC, Johnston RB, Jr., Boyle J, Curnutte J, et al. (2000) Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 79: 155-169.
41. Chonchol M (2006) Neutrophil Dysfunction and Infection Risk in End-Stage Renal Disease. Semin Dial 19: 291-296.
42. Pollock JD, Williams DA, Gifford MAC, Li LL, Du X, et al. (1995) Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat Genet 9: 202-209.
43. Serhan CN, Savill J (2005) Resolution of inflammation: the beginning programs the end. Nat Immunol 6: 1191-1197.
44. Clark SR, Ma AC, Tavener SA, McDonald B, Goodarzi Z, et al. (2007) Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med 13: 463-469.
45. Carlsson G, Andersson M, Putsep K, Garwicz D, Nordenskjold M, et al. (2006) Kostmann syndrome or infantile genetic agranulocytosis, part one: Celebrating 50 years of clinical and basic research on severe congenital neutropenia. Acta Paediatr 95: 1526-1532.
46. Scheel-Toellner D, Wang K, Craddock R, Webb PR, McGettrick HM, et al. (2004) Reactive oxygen species limit neutrophil life span by activating death receptor signaling. Blood 104: 2557-2564.
47. Björkman L, Dahlgren C, Karlsson A, Brown KL, Bylund J (2008) Phagocyte-derived reactive oxygen species as suppressors of inflammatory disease. Arthritis Rheum 58: 2931-2935.
48. Amar S, Zhou Q, Shaik-Dasthagirisaheb Y, Leeman S (2007) Diet-induced obesity in mice causes changes in immune responses and bone loss manifested by bacterial challenge. Proc Natl Acad Sci U S A 104: 20466-20471.
49. Saito T, Shimazaki Y, Koga T, Tsuzuki M, Ohshima A (2001) Relationship between upper body obesity and periodontitis. J Dent Res 80: 1631-1636.
50. Shamshiev AT, Ampenberger F, Ernst B, Rohrer L, Marsland BJ, et al. (2007) Dyslipidemia inhibits Toll-like receptor-induced activation of CD8alpha-negative dendritic cells and protective Th1 type immunity. J Exp Med 204: 441-452.
51. Jiang T, Wang Z, Proctor G, Moskowitz S, Liebman SE, et al. (2005) Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway. J Biol Chem 280: 32317-32325.
52. Dixon JB, O'Brien PE (2006) Obesity and the white blood cell count: changes with sustained weight loss. Obes Surg 16: 251-257.
53. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, et al. (1998) Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394: 897-901.
54. Farooqi IS, Matarese G, Lord GM, Keogh JM, Lawrence E, et al. (2002) Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 110: 1093-1103.
55. Faggioni R, Fantuzzi G, Gabay C, Moser A, Dinarello CA, et al. (1999) Leptin deficiency enhances sensitivity to endotoxin-induced lethality. Am J Physiol 276: R136-142.